30.73 USD
▲-0.29+7.82%
盘后 28.41 -0.32%
2026-08-03
市值
$1.36B
市盈率
—
EPS
-78.19
股息率
—
52 周区间
24.15 – 33.32
成交量
176.67K
Beta
—
目标价
59.00
52W 低 24.1552W 高 33.32
价格走势
公司简介
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose ...